Rethinking de novo immune hepatitis, an old concept for liver allograft rejection: Relevance of glutathione S-transferase T1 mismatch

Autor: J.M. Sousa, Elena Aguado-Dominguez, Antonio Núñez-Roldán, Isabel Aguilera
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Graft Rejection
medicine.medical_treatment
Biopsy
Plasma Cells
T lymphocytes
Context (language use)
Autoimmune hepatitis
Human leukocyte antigen
030230 surgery
Liver transplantation
Major histocompatibility complex
Cell quantification
03 medical and health sciences
0302 clinical medicine
Antigen
Histocompatibility Antigens
medicine
Humans
Transplantation
Homologous

Liver allograft rejection
Autoantibodies
Glutathione Transferase
biology
business.industry
De novo autoimmune hepatitis
Donor-specific antibodies
Gastroenterology
Autoantibody
Glutathione S-transferase T1 mismatch
Minireviews
General Medicine
NewCAST
medicine.disease
Allografts
Plasma cell-rich rejection
Liver Transplantation
Hepatitis
Autoimmune

Liver
Immunoglobulin G
Immunology
biology.protein
030211 gastroenterology & hepatology
Antibody
IgG4+ plasma cell
business
Zdroj: World Journal of Gastroenterology
Popis: Antibody-mediated rejection (AMR) in liver transplantation has long been underestimated. The concept of the liver as an organ susceptible to AMR has emerged in recent years, not only in the context of the major histocompatibility complex with the presence of HLA donor-specific antibodies, but also with antigens regarded as “minor”, whose role in AMR has been demonstrated. Among them, antibodies against glutathione S-transferase T1 have been found in 100% of patients with de novo autoimmune hepatitis (dnAIH) when studied. In its latest update, the Banff Working Group for liver allograft pathology proposed replacing the term dnAIH with plasma cell (PC)-rich rejection. Antibodies to glutathione S-transferase T1 (GSTT1) in null recipients of GSTT1 positive donors have been included as a contributory but nonessential feature of the diagnosis of PC-rich rejection. Also in this update, non-organ-specific anti-nuclear or smooth muscle autoantibodies are no longer included as diagnostic criteria. Although initially found in a proportion of patients with PC-rich rejection, the presence of autoantibodies is misleading since they are not disease-specific and appear in many different contexts as bystanders. The cellular types and proportions of the inflammatory infiltrates in diagnostic biopsies have been studied in detail very recently. PC-rich rejection biopsies present a characteristic cellular profile with a predominance of T lymphocytes and a high proportion of PCs, close to 30%, of which 16.48% are IgG4+. New data on the relevance of GSTT1-specific T lymphocytes to PC-rich rejection will be discussed in this review.
Databáze: OpenAIRE